← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2009Last known activity
Oct 31, 2024
Timeline
1980s
- Jun 1, 1987
Soligenix— Founded
Drugs by trial phase (4 distinct, 12 trials)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (13)
- NCT06470451Lead sponsorPhase 3Oct 31, 2024
- NCT06386744Lead sponsorPhase 2Jul 31, 2024
- NCT06149247Lead sponsorPhase 2Dec 5, 2023
- NCT05872854CollaboratorPhase 2Aug 21, 2023
- NCT05442190Lead sponsorPhase 2Dec 14, 2022
- NCT05380635Lead sponsorPhase 2May 9, 2022
- NCT03237325Lead sponsorPhase 3Jul 25, 2017
- NCT02448381Lead sponsorPhase 3Dec 1, 2015
- NCT02013050Lead sponsorPhase 2Dec 1, 2013
- NCT01925950Lead sponsorPhase 2Dec 1, 2013
- NCT01073384Overall official - principal investigatorPhase 1/Phase 2Dec 1, 2009
- NCT01073384Lead sponsorPhase 1/Phase 2Dec 1, 2009
- NCT00926575Lead sponsorPhase 3Oct 1, 2009
Details
- Founded
- Princeton, NJ, US Jun 1, 1987
- Last known activity
- Oct 31, 2024